| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |